SeaStar Medical (ICU) Latest Stock Analysis Report β Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $3.06, +1.66% vs the prior close of $3.01.
- Volume 206.30K shares, 1.7x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
ICU rises 1.7% to $3.06. Closed at $3.06, +1.66% vs the prior close of $3.01. Day range $2.89β$3.13, opened at $3.01.
ICU daily analysis β what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 β ICU rises 1.7% to $3.06
- Closed at $3.06, +1.66% vs the prior close of $3.01. Day range $2.89β$3.13, opened at $3.01.
- Volume was 206.30K shares, 1.7x its 50-day average of 122.78K.
- Price is -8.3% vs its 50-day average ($3.34) and -7.8% vs its 200-day average ($3.32).
- 52-week range $2.07β$7.35; today's close sits at 19% of that range, 58.4% below the 52-week high.
Oct 14, 2026 β ICU slides 16.2% to $3.01, a 1-month low on 4.4x normal volume
- Closed at $3.01, -16.16% vs the prior close of $3.59. Day range $2.87β$3.62, opened at $3.59.
- Volume was 502.60K shares, 4.4x its 50-day average of 114.05K β unusually heavy trading.
- Price is -9.8% vs its 50-day average ($3.34) and -9.2% vs its 200-day average ($3.31).
- 52-week range $2.07β$7.35; today's close sits at 18% of that range, 59.0% below the 52-week high.
Oct 13, 2026 β ICU slides 6.8% to $3.59
- Closed at $3.59, -6.75% vs the prior close of $3.85. Day range $3.50β$3.92, opened at $3.88.
- Volume was 124.80K shares, 1.1x its 50-day average of 112.50K.
- Price is +7.5% vs its 50-day average ($3.34) and +8.4% vs its 200-day average ($3.31).
- 52-week range $2.07β$7.35; today's close sits at 29% of that range, 51.2% below the 52-week high.
Oct 12, 2026 β ICU jumps 6.6% to $3.85
- Closed at $3.85, +6.65% vs the prior close of $3.61. Day range $3.51β$3.95, opened at $3.55.
- Volume was 116.10K shares, 1.0x its 50-day average of 111.87K.
- Price is +15.5% vs its 50-day average ($3.33) and +16.5% vs its 200-day average ($3.31).
- 52-week range $2.07β$7.35; today's close sits at 34% of that range, 47.6% below the 52-week high.
Oct 9, 2026 β ICU jumps 3.4% to $3.61
- Closed at $3.61, +3.44% vs the prior close of $3.49. Day range $3.31β$3.63, opened at $3.57.
- Volume was 104.40K shares, 0.9x its 50-day average of 110.76K.
- Price is +8.8% vs its 50-day average ($3.32) and +9.5% vs its 200-day average ($3.30).
- 52-week range $2.07β$7.35; today's close sits at 29% of that range, 50.9% below the 52-week high.
Oct 8, 2026 β ICU slides 6.2% to $3.49 on 1.9x normal volume
- Closed at $3.49, -6.18% vs the prior close of $3.72. Day range $3.33β$3.72, opened at $3.59.
- Volume was 209.10K shares, 1.9x its 50-day average of 107.80K β unusually heavy trading.
- Price is +5.5% vs its 50-day average ($3.31) and +6.0% vs its 200-day average ($3.29).
- 52-week range $2.07β$7.35; today's close sits at 27% of that range, 52.5% below the 52-week high.
Oct 7, 2026 β ICU jumps 16.6% to $3.72 on 16.7x normal volume
- Closed at $3.72, +16.61% vs the prior close of $3.19. Day range $3.05β$3.77, opened at $3.26.
- Volume was 1.36M shares, 16.7x its 50-day average of 81.37K β unusually heavy trading.
- Price is +12.6% vs its 50-day average ($3.30) and +13.2% vs its 200-day average ($3.29).
- 52-week range $2.07β$7.35; today's close sits at 31% of that range, 49.4% below the 52-week high.
Oct 6, 2026 β ICU slides 10.1% to $3.19 on 3.8x normal volume
- Closed at $3.19, -10.14% vs the prior close of $3.55. Day range $3.07β$3.50, opened at $3.48.
- Volume was 292.70K shares, 3.8x its 50-day average of 76.85K β unusually heavy trading.
- Price is -3.3% vs its 50-day average ($3.30) and -2.9% vs its 200-day average ($3.28).
- 52-week range $2.07β$7.35; today's close sits at 21% of that range, 56.6% below the 52-week high.
Oct 5, 2026 β ICU slides 24.3% to $3.55 on 8.9x normal volume
- Closed at $3.55, -24.31% vs the prior close of $4.69. Day range $3.44β$3.74, opened at $3.62.
- Volume was 593.90K shares, 8.9x its 50-day average of 66.54K β unusually heavy trading.
- Price is +7.4% vs its 50-day average ($3.31) and +8.2% vs its 200-day average ($3.28).
- 52-week range $2.07β$7.35; today's close sits at 28% of that range, 51.7% below the 52-week high.
- SEC filings that day: 8-K.
Oct 2, 2026 β ICU jumps 25.1% to $4.69, a 1-month high on 9.0x normal volume
- Closed at $4.69, +25.07% vs the prior close of $3.75. Day range $3.68β$4.80, opened at $3.78.
- Volume was 515.60K shares, 9.0x its 50-day average of 57.60K β unusually heavy trading.
- Price is +41.7% vs its 50-day average ($3.31) and +43.0% vs its 200-day average ($3.28).
- 52-week range $2.07β$7.35; today's close sits at 50% of that range, 36.2% below the 52-week high.
ICU latest news & SEC filings
Every SEC filing by or about ICU in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 5, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 1.01 β Signed a material agreement.
- Item 3.02 β Sold unregistered shares.
- Item 8.01 β Reported other events the company considers important.
Aug 19, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
- Messinger Michael bought 750 shares at $3.27 (β$2.45K) on Aug 18, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 12, 2026 Β· Form 10-Q β Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $615.00K (prior year $338.00K) (+82.0% vs Jun 30, 2025)
- Net income: -$3.73M (prior year -$2.00M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.91 (prior year -$1.77) (loss narrowed vs Jun 30, 2025)
Aug 12, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 2.02 β Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 21, 2026 Β· Form S-8 β Employee share plan registration
Registration of shares for employee stock plans (S-8)
Jul 2, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 2, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 2, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 2, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 2, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 1, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 5.02 β Change in directors or officers (appointment, departure or pay).
Jun 23, 2026 Β· Form 8-K/A β Current report (amended)
Amended current report
- Item 5.02 β Change in directors or officers (appointment, departure or pay).
Things to know before you trade ICU
- Last results release: Aug 12, 2026 (8-K Item 2.02). Previous ones: May 13, 2026, Mar 25, 2026, Nov 13, 2025. Based on that rhythm, the next report is likely around Nov 11, 2026 β an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 7.23% (largest 25.1%). That is a volatile stock.
- Liquidity: about 223.26K shares (β$683.18K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $3.06 vs a range of $2.07β$7.35 (19% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:10 on Jan 5, 2026
- Insider trades (Form 4, last 12 months, recent 25 shown): 3 open-market buys, 0 sales; latest: Michael Messinger bought 750 shares on Aug 18, 2026.
- Latest filings: 8-K Oct 5, 2026; 10-Q Aug 12, 2026; 8-K Aug 12, 2026.
- Share count: 4.41M shares outstanding (Aug 5, 2026), -84.2% vs a year earlier β the company has been reducing its share count.
- Listing: Nasdaq Β· industry: Surgical & Medical Instruments & Apparatus.
ICU market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 3.01 | 3.13 | 2.89 | 3.06 | 206.30K |
| Oct 14, 2026 | 3.59 | 3.62 | 2.87 | 3.01 | 502.60K |
| Oct 13, 2026 | 3.88 | 3.92 | 3.50 | 3.59 | 124.80K |
| Oct 12, 2026 | 3.55 | 3.95 | 3.51 | 3.85 | 116.10K |
| Oct 9, 2026 | 3.57 | 3.63 | 3.31 | 3.61 | 104.40K |
| Oct 8, 2026 | 3.59 | 3.72 | 3.33 | 3.49 | 209.10K |
| Oct 7, 2026 | 3.26 | 3.77 | 3.05 | 3.72 | 1.36M |
| Oct 6, 2026 | 3.48 | 3.50 | 3.07 | 3.19 | 292.70K |
| Oct 5, 2026 | 3.62 | 3.74 | 3.44 | 3.55 | 593.90K |
| Oct 2, 2026 | 3.78 | 4.80 | 3.68 | 4.69 | 515.60K |
| Oct 1, 2026 | 3.99 | 3.99 | 3.71 | 3.75 | 28.30K |
| Sep 30, 2026 | 3.62 | 4.09 | 3.62 | 3.94 | 86.70K |
| Sep 29, 2026 | 3.40 | 3.75 | 3.26 | 3.56 | 135.10K |
| Sep 28, 2026 | 3.42 | 3.42 | 3.33 | 3.40 | 10.40K |
| Sep 25, 2026 | 3.48 | 3.54 | 3.39 | 3.42 | 30.00K |
| Sep 24, 2026 | 3.45 | 3.51 | 3.22 | 3.44 | 13.90K |
| Sep 23, 2026 | 3.55 | 3.60 | 3.45 | 3.53 | 11.50K |
| Sep 22, 2026 | 3.58 | 3.60 | 3.42 | 3.53 | 22.10K |
| Sep 21, 2026 | 3.57 | 3.58 | 3.33 | 3.58 | 22.50K |
| Sep 18, 2026 | 3.51 | 3.68 | 3.43 | 3.54 | 77.80K |
About SeaStar Medical
SeaStar Medical (ICU) is listed on the Nasdaq and classified by the SEC under βSurgical & Medical Instruments & Apparatusβ. Its business address is in DENVER, CO. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1831868.
ICU board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Jennifer A Baird | Director | Jul 2, 2026 |
| John Neuman | Director | Jul 2, 2026 |
| Heel Kenneth Van | Director | Jul 2, 2026 |
| Bernadette N Vincent | Director | Jul 2, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Kevin Chung | Chief Medical Officer | Jul 2, 2026 |
| Michael Messinger | Chief Financial Officer | Aug 19, 2026 |
| Eric Schlorff | Chief Executive Officer | Jul 2, 2026 |
| Bradford K Towne | Principal Accounting Officer | Feb 10, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 18, 2026 | Michael Messinger | Buy | 750 | $3.27 |
| Dec 19, 2025 | Jennifer A Baird | Buy | 4,200 | $0.24 |
| Dec 9, 2025 | Michael Messinger | Buy | 14,500 | $0.35 |
ICU financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $1.23M | $-12.15M | β | $-13.60M |
| Dec 31, 2024 | $135.00K | $-24.83M | -6.63 | $-16.01M |
| Dec 31, 2023 | $0 | $-26.23M | -30.26 | $-10.29M |
| Dec 31, 2022 | β | $-12.19M | -1.48 | $-7.79M |
| Dec 31, 2021 | β | $-4.60M | -0.63 | $-5.11M |
Latest balance sheet: total assets $8.65M, total liabilities $4.35M, cash $51.57K (as of Jun 30, 2026).
ICU earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 12, 2026 | 8-K Item 2.02 (results) | $3.36 |
| May 13, 2026 | 8-K Item 2.02 (results) | $4.60 |
| Mar 25, 2026 | 8-K Item 2.02 (results) | $2.28 |
| Nov 13, 2025 | 8-K Item 2.02 (results) | $4.60 |
| May 14, 2025 | 8-K Item 2.02 (results) | $12.30 |
| Mar 27, 2025 | 8-K Item 2.02 (results) | $22.00 |
| Nov 13, 2024 | 8-K Item 2.02 (results) | $25.20 |
| May 14, 2024 | 8-K Item 2.02 (results) | β |
| Apr 17, 2024 | 8-K Item 2.02 (results) | β |
| Nov 22, 2023 | 8-K Item 2.02 (results) | β |
| Aug 15, 2023 | 8-K Item 2.02 (results) | β |
| May 16, 2023 | 8-K Item 2.02 (results) | β |
Related stocks Β· Surgical & Medical Instruments & Apparatus
Stryker (SYK)Boston Scientific (BSX)3M (MMM)MiniMed (MMED)Dexcom (DXCM)Becton Dickinson (BDX)Medline (MDLN)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on ICU
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.